Experienced in Hemolytic Anemia

Miguel Blanquer

Murcia, MU, ES 
Experienced in Hemolytic Anemia
Murcia, MU, ES 
OverviewLocationsClinical Research

Overview

Miguel Blanquer practices in Murcia, Spain. Mr. Blanquer is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Anemia, Hereditary Pyropoikilocytosis, and Bone Marrow Transplant.

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hemolytic Anemia.

Gender
Male

Locations

Murcia, MU 30120, Spain
Other Locations
El Palmar, MU 30120, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Clinical Trial Phase I / II Graft Versus Host Disease Treatment Refractory to First-line Therapy With Sequential Infusion of Mesenchymal Cells Allogeneic Expanded Adipose Tissue in Vitro
Clinical Trial Phase I / II Graft Versus Host Disease Treatment Refractory to First-line Therapy With Sequential Infusion of Mesenchymal Cells Allogeneic Expanded Adipose Tissue in Vitro
Enrollment Status: Completed
Publish Date: October 13, 2022
Intervention Type: Drug
Study Drug: Adult Allogeneic Mesenchymal Cells from Adipose Tissue
Study Phase: Phase 1/Phase 2
Phase I Clinical Trial To Evaluate The Intravenous Infusion Of Autologous Fucosylated Bone Marrow Mesenchymal Cells Therapy In Patients With Established Osteoporosis and Low Impact Fractures
Phase I Clinical Trial To Evaluate The Intravenous Infusion Of Autologous Fucosylated Bone Marrow Mesenchymal Cells Therapy In Patients With Established Osteoporosis and Low Impact Fractures
Enrollment Status: Completed
Publish Date: October 08, 2020
Intervention Type: Biological
Study Phase: Phase 1
Phase I Clinical Trial on Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis.
Phase I Clinical Trial on Intramuscular Infusion of Autologous Bone Marrow Stem Cells in Patients With Amyotrophic Lateral Sclerosis.
Enrollment Status: Unknown
Publish Date: March 30, 2017
Intervention Type: Biological, Other
Study Drug: MNC (Mononuclear Cells)
Study Phase: Phase 1
Phase I Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Phase I Clinical Trial of Intravitreal Injection of Autologous Bone Marrow Stem Cells in Patients With Retinitis Pigmentosa
Enrollment Status: Completed
Publish Date: March 30, 2017
Intervention Type: Other, Biological
Study Phase: Phase 1
View 3 Less Clinical Trials

50 Total Publications

TRAP-Induced Platelet Reactivity Is Inhibited by Omega-3 Fatty Acid-Derived Prostaglandin E3 (PGE3).
TRAP-Induced Platelet Reactivity Is Inhibited by Omega-3 Fatty Acid-Derived Prostaglandin E3 (PGE3).
Journal: Biomedicines
Published: November 16, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Blanquer's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile